The fusion or amplification of TFE3 has been identified with molecular events such as perivascular epithelioid cell tumours (PEComas) and renal cell carcinoma associated with Xp11.2 translocation [22–24]. This evidence concerns the gene TFE3 and neoplasm with perivascular epithelioid cell differentiation.